Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-05-05
2000-12-26
Borin, Michael
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 530303, A61K 3828, C07K 1462
Patent
active
061659762
ABSTRACT:
A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.
REFERENCES:
patent: 4524769 (1985-06-01), Wetterlin
patent: 4534345 (1985-08-01), Wetterlin
patent: 4537772 (1985-08-01), Alexander
patent: 4548922 (1985-10-01), Carey et al.
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4668218 (1987-05-01), Virtanen
patent: 4690952 (1987-09-01), Kagatani et al.
patent: 4731360 (1988-03-01), Alexander
patent: 4746508 (1988-05-01), Carey et al.
patent: 4788221 (1988-11-01), Kagatani et al.
patent: 4900730 (1990-02-01), Miyauchi
patent: 4907583 (1990-03-01), Wetterlin et al.
patent: 4959358 (1990-09-01), Carey et al.
patent: 5006343 (1991-04-01), Benson et al.
patent: 5179079 (1993-01-01), Hansen et al.
patent: 5202129 (1993-04-01), Samejima et al.
patent: 5284656 (1994-02-01), Platz et al.
patent: 5320094 (1994-06-01), Laube et al.
patent: 5341800 (1994-08-01), Clark et al.
patent: 5354562 (1994-10-01), Platz et al.
patent: 5364838 (1994-11-01), Rubsamen
patent: 5419315 (1995-05-01), Rubsamen
patent: 5451569 (1995-09-01), Wong et al.
patent: 5607915 (1997-03-01), Patton
patent: 5661130 (1997-08-01), Meezan et al.
patent: 5707644 (1998-01-01), Illum
patent: 5730969 (1998-03-01), Hora et al.
patent: 5814607 (1998-09-01), Patton
patent: 5830863 (1998-11-01), Backstrom
patent: 5997848 (1999-12-01), Patton et al.
patent: 6051256 (2000-04-01), Platz et al.
Byron et al., "Drug Delivery via the Respiratory . . . , " Journal of Aerosol Medicine, 7:49-75, 1994.
Nagano et al., "New Method of Insulin . . . ," Jikeikai Med. J., 32:503-506, 1985.
Elliott et al., "Parenteral absorption of insulin . . . ," Aust. Paediatr. J., 23:293-297, 1987.
Sakr., "A new approach for insulin . . . ," International Journal of Pharmaceutics, 86:1-7, 1992.
Liu et al., "Pulmonary Delivery of Free . . . ," Pharmaceutical Research, 10:228-232, 1993.
Wang et al. J. Parenteral Science and Technology, 42 (2S), S4-S26, 1988.
Chien et al., "Intranasal Drug Delivery for Systemic Medications", CRC Critical Reviews in Therapeutic Drug Carrier Systems 4:67-194, 1987.
Eppstein et al., "Alternative Delivery Systems for Peptides and Proteins As Drugs", CRC Critical Reviews in Therapeutic Drug Carrier System 5:99-139, 1988.
O'Hagan et al., "Absorption of Peptides and Proteins from the Respiratory Tract and the Potential for Development of Locally Administered Vaccine", Critical Reviews in Therapeutic Drug Carrier Sys 7:35-97, 1990.
Allenby et al., The Absorption of Insulin Across the Respiratory Tract of the Guinea-Pig (U), The Aerosol Society, Fourth Annual Conference 1990, pp. 129-134.
Aungst and Rogers, Comparison of the Effects of Various Transmucosal Absorption Promoters on Buccal Insulin Delivery, Int. J. Pharm. (Netherlands), 1989, 53/3, 227-235.
Bjork, Starch Microspheres as a Nasal Delivery System for Drugs, Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 103, 1993.
Bjork and Edman, Degradable Starch Microspheres as a Nasal Delivery System for Insulin, Int. J. Pharm. 47:233-238, 1988.
Brange et al., Monomeric Insulins and Their Experimental and Clinical Implications, Diabetes Care 13:923-954, 1990.
Edman and Bjork, Routes of Delivery Case Studies, Advanced Drug Delivery Reviews 8:165-177, 1992.
Igawa et al., Effect of Absorption Promoters in Intranasal Administration of Human Fibroblast Interferon as a Powder Dosage Form in Rabbits, chem. Pharm. Bull. 37:418-421, 1989.
Komada et al., Intratracheal Delivery of Peptide and Protein Agents: Absorption from Solution and Dry Powder by Rat Lung, J. Pharm. Sci. 83:863-867, 1994.
Lasker, The Diabetes Control and Complications Trial, N. Engl. J. Med. 329:1035-1036, 1993.
Laube et al., Preliminary Study of the Efficacy of Insulin Aerosol Delivered by Oral Inhalation in Diabetic Patients, JAMA 269:2106-2109, 1993.
Lee et al., Intranasal Bioavailability of Insulin in Powder Formulations: Effect of Permeation Enhancer-to-Protein Ratio, J. Pharm. Sci. 80:725-729, 1991.
Mishima et al., Studies on the Promoting Effects of Medium Chain Fatty Acid Salts on the Nasal Absorption of Insulin in Rats, J. Pharma -Dyn. 10:624-631, 1987.
Morita et al., Effects of Various Absorption Promoters on Pulumonary Absorption of Drugs with Different Molecular Weights, Biol. Pharm. Bull. 16:269-262, 1993.
Nagai et al., Powder Dosage Form of Insulin for Nasal Administration, J. Controlled Release 1:15-22, 1984.
"Diabetes Mellitus", Ch. VI in Scientific American Medicine, Scientific American, Inc., Apr. 1993.
The Diabetes Control and Complications Trial Research Group, The Effect of Intensive Treatment of Diabetes on the Development . . . Complications in Insulin-Dependent Diabetes Mellitus, N. Engl. J. Med. 329:977-86, 1993.
Pontiroli et al., Nasal Administration of Glucagon and Human Calcitonin to Healthy Subjects: a Comparison of Powders and Spray Solutions and of Different Enhancing Agents, Eur. J. Clin. Pharmacol. 37:427-430, 1989.
Schipper et al., Nasal Insulin Delivery with Dimethyl-.beta.-Cyclodextrim as an Absorption Enhancer in Rabbits: Powder More Effective than Liquid Formulations, Pharmaceutical Research 10:682-686, 1993.
Selam and Charles, Devices for Insulin Administration, Diabetes Care 13:955-979, 1990.
Touitou and Rubenstein, Targeted Enteral Delivery of Insulin to Rats, Int. J. Pharm. (Amst.), 30(2-3), 1986, 95-100.
Wigley et al., Insulin Across Respiratory Mucosae by Aerosol Delivery, Diabetes 20:552-556, 1971.
Zinman, Medical Intelligence--The Physiologic Replacement of Insulin, N. Engl. J. Med. 321:363-370, 1989.
Olanoff et al., "Method to Enhance Intranasal Peptide Delivery," in "Controlled-Release Technology Pharmaceutical Applications" Lee et al., American Chemical Societ, 301-309, 1987.
Backstrom Kjell Goran Erik
Dahlback Carl Magnus Olof
Edman Peter
Johansson Ann Charlotte Birgit
Astra Aktiebolag
Borin Michael
LandOfFree
Therapeutic preparation for inhalation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic preparation for inhalation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic preparation for inhalation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-994867